Cardiff Oncology, Inc.

Cardiff Oncology, Inc.

Cardiff Oncology, Inc.

Overview
Date Founded

2009

Headquarters

11055 Flintkote Avenue, San Diego, CA, 92121, USA

Type of Company

Public

Employees (Worldwide)

12

Industries

Medical Support Services
Hospitals & Patient Services
IT Consulting & Services
Biotechnology

Company Description

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. The firm's clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.

Contact Data
Trying to get in touch with decision makers at Cardiff Oncology, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Vice President, Finance, Principal Financial Officer & Principal Accounting Officer

Executive Vice President & Chief Operating Officer

Senior Director

Staff Scientist

Accounting Associate

Board of Directors

Associate Vice Chancellor for Business Development at University of Nebraska Medical Center

Chief Financial Officer at Orchestra Medical Ventures LLC

Founder at Sova Pharmaceuticals, Inc.

Founder at XIFIN, Inc.

Professor-Internal Medicine at University of Nebraska Medical Center

Chief Executive Officer & Director at OKYO Pharma Ltd.

Chief Executive Officer at Cardiff Oncology, Inc.

Executive Director & Head-Drug Development at Tiziana Life Sciences Plc

Paths to Cardiff Oncology, Inc.
Potential Connections via
Relationship Science
You
Cardiff Oncology, Inc.
Owners & Shareholders
Details Hidden

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization.

Details Hidden

Avidity Partners Management LP (APM) is a hedge fund manager headquartered in Dallas, Texas founded by Michael David Gregory. APM provides investment advice.

Details Hidden

Corriente Advisors invests in the public equity and alternative investment markets in the US. The firm employs a combination of in-house and external research to construct its portfolios.

Recent Transactions
Details Hidden

Cardiff Oncology, Inc. issued USD Common Stock

Details Hidden

Cardiff Oncology, Inc. issued USD Units Consisting of Common Stock and Warrants

Details Hidden

Cardiff Oncology, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Auditor

Advised onCardiff Oncology, Inc. issued USD Common Stock

Escrow Agent

Advised onCardiff Oncology, Inc. issued USD Common Stock

Underwriter

Advised onCardiff Oncology, Inc. issued USD Common Stock

Legal Advisor

Advised onCardiff Oncology, Inc. issued USD Common Stock

Legal Advisor

Advised onCardiff Oncology, Inc. issued USD Common Stock

Managing Director

Advised onCardiff Oncology, Inc. issued USD Common Stock

Advisors & Consultants
Publicist

Corporate Practice Counsel at Inventiv Health Public Relations

Key Stats and Financials As of 2020
Market Capitalization
$364M
Total Enterprise Value
$245M
Earnings Per Share
$-1.08
Net Profit
$-19.3M
EBITDA
$-18.6M
EBITDAMargin
-5,078.15%
Enterprise Value / Sales
670.57x
TEVNet Income
-12.71x
Debt TEV
0x
Total Debt
$870K
Total Equity
$130M
Three Year Compounded Annual Growth Rate Of Revenue
-10.2%
Revenue
$366K
Non-Profit Donations & Grants
Suppliers
Columbia University Social Interest | New York, NY

Columbia University is one of the world's most important centers of research and at the same time a distinctive and distinguished learning environment for undergraduates and graduate students in many scholarly and professional fields. The University recognizes the importance of its location in New York City and seeks to link its research and teaching to the vast resources of a great metropolis. It seeks to attract a diverse and international faculty and student body, to support research and teaching on global issues, and to create academic relationships with many countries and regions. It expects all areas of the university to advance knowledge and learning at the highest level and to convey the products of its efforts to the world.

Nerviano Medical Sciences SRL Pharmaceuticals | Nerviano, Italy

Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy.

Massachusetts Institute of Technology Hospitals & Patient Services | Cambridge, Massachusetts

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Competitors
GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Cyclacel Pharmaceuticals Inc. Pharmaceuticals - Berkeley Heights, NJ

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.

Onconova Therapeutics, Inc. Pharmaceuticals - Newtown, Pennsylvania

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cardiff Oncology, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cardiff Oncology, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cardiff Oncology, Inc..